GeneDx Holdings (WGS) Profit After Tax Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 33.71% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 12.84% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 25.51% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -20.26% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 113.17% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 99.81% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -39.81% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 3,373.98% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -55.93% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -267.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -267.28% |
| Mar 31, 2026 | -873.64% |
| Dec 31, 2025 | -424.86% |
| Sep 30, 2025 | 8.14% |
| Jun 30, 2025 | 137.05% |
| Mar 31, 2025 | 67.95% |
| Dec 31, 2024 | 121.10% |
| Sep 30, 2024 | 80.34% |
| Jun 30, 2024 | 37.56% |
| Mar 31, 2024 | 66.60% |
| Dec 31, 2023 | 91.65% |
| Sep 30, 2023 | 45.49% |
| Jun 30, 2023 | 45.51% |
| Mar 31, 2023 | 20.69% |
| Dec 31, 2022 | -668.35% |
| Sep 30, 2022 | -337.03% |
| Jun 30, 2022 | -85.75% |
| Mar 31, 2022 | 59.90% |
| Dec 31, 2021 | 68.03% |
| Sep 30, 2021 | 157.81% |